US Stocks

Bicycle Therapeutics plc

Bicycle Therapeutics is a biopharmaceutical company that designs medicines for diseases with inadequate therapeutics. The company has several products in clinical and preclinical trials, including BT1718, BT7480, BT7455, and BT8009, aiming to target specific types of tumors. Bicycle Therapeutics collaborates with other companies and organizations on a range of therapeutic areas and was established in 2009 in Cambridge, UK.